| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant systemic treatment of early breast cancer: the NORA study
|
Cazzaniga, M.E.
|
|
|
17 |
9 |
p. 1386-1392
|
artikel
|
| 2 |
Adjuvant therapy in colon cancer—what, when and how?
|
Chau, I.
|
|
|
17 |
9 |
p. 1347-1359
|
artikel
|
| 3 |
A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy
|
Aapro, M.S.
|
|
|
17 |
9 |
p. 1441-1449
|
artikel
|
| 4 |
A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the eastern cooperative oncology group study E2200
|
Giantonio, B.J.
|
|
|
17 |
9 |
p. 1399-1403
|
artikel
|
| 5 |
A phase II trial of neoadjuvant cisplatin–fluorouracil followed by postoperative intraperitoneal floxuridine–leucovorin in patients with locally advanced gastric cancer
|
Brenner, B.
|
|
|
17 |
9 |
p. 1404-1411
|
artikel
|
| 6 |
Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration
|
Semple, S.I.K.
|
|
|
17 |
9 |
p. 1393-1398
|
artikel
|
| 7 |
Body size and laryngeal cancer risk
|
Garavello, W.
|
|
|
17 |
9 |
p. 1459-1463
|
artikel
|
| 8 |
Buprenorphine-induced acute respiratory depression during ifosfamide-based chemotherapy
|
Moro, C.
|
|
|
17 |
9 |
p. 1466-1467
|
artikel
|
| 9 |
Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy
|
Wedding, U.
|
|
|
17 |
9 |
p. 1468-1469
|
artikel
|
| 10 |
Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage?
|
Leonard, R.
|
|
|
17 |
9 |
p. 1379-1385
|
artikel
|
| 11 |
Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy
|
Visco, C.
|
|
|
17 |
9 |
p. 1434-1440
|
artikel
|
| 12 |
Factors that influence cancer patients' anxiety following a medical consultation: impact of a communication skills training programme for physicians
|
Liénard, A.
|
|
|
17 |
9 |
p. 1450-1458
|
artikel
|
| 13 |
High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complication
|
Cabanillas, F.
|
|
|
17 |
9 |
p. 1424-1427
|
artikel
|
| 14 |
In response to: ‘On prejudice and facts and choices’, an editorial by Köhne and Folprecht
|
Cassidy, J.
|
|
|
17 |
9 |
p. 1469-1471
|
artikel
|
| 15 |
in this issue
|
|
|
|
17 |
9 |
p. 1339
|
artikel
|
| 16 |
KISS: the 2006 Annals of Oncology prizes
|
Kerr, David J.
|
|
|
17 |
9 |
p. 1341-1342
|
artikel
|
| 17 |
Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network
|
Kahl, B.S.
|
|
|
17 |
9 |
p. 1418-1423
|
artikel
|
| 18 |
Management of neuromuscular dose limiting toxicity at the early stage of drug development
|
Faivre, S.
|
|
|
17 |
9 |
p. 1343-1346
|
artikel
|
| 19 |
Neo-adjuvant chemotherapy for muscle-invasive bladder cancer: a look ahead
|
Sawhney, R.
|
|
|
17 |
9 |
p. 1360-1369
|
artikel
|
| 20 |
Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study
|
Cortot, A.B.
|
|
|
17 |
9 |
p. 1412-1417
|
artikel
|
| 21 |
Phase I study of Aplidine in a daily×5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115
|
Maroun, J.A.
|
|
|
17 |
9 |
p. 1371-1378
|
artikel
|
| 22 |
Promotion of neurogenesis by human stem cells in high-risk breast cancer survivals after stem-cell supported high-dose therapy
|
Altundag, K.
|
|
|
17 |
9 |
p. 1465
|
artikel
|
| 23 |
Reply to ‘Promotion of neurogenesis by human stem cells in high-risk breast cancer survivals after stem-cell supported high-dose therapy’ by K. Altundag et al. (Ann Oncol 2006; 17: 1465)
|
Scherwath, A.
|
|
|
17 |
9 |
p. 1465-1466
|
artikel
|
| 24 |
Table of Contents
|
|
|
|
17 |
9 |
p. ii-iii
|
artikel
|
| 25 |
Treatment-related premature ovarian failure as a long-term complication after Hodgkin's lymphoma
|
Haukvik, U.K.H.
|
|
|
17 |
9 |
p. 1428-1433
|
artikel
|
| 26 |
Vascular endothelial growth factor 936 C/T polymorphism in cancer patients
|
Eroglu, A.
|
|
|
17 |
9 |
p. 1467-1468
|
artikel
|
Tijdschrift beschrijving